Light-based imaging to detect nerve inflammation in GBS and CIDP
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study uses a new light-based imaging technique to look at nerve inflammation and damage in people with Guillain-Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP). It may help doctors better understand and monitor these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed or suspected diagnosis of GBS or CIDP.
- You are willing to give written consent to participate.
- You are not pregnant or breastfeeding.
- You do not have a tattoo in the area to be examined (like the arm or leg).
- Your subcutaneous fat (the layer under the skin) is not thicker than 3 cm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving immune globulin under the skin (SCIG) can help people with newly diagnosed CIDP. It may help improve muscle strength and nerve symptoms while avoiding the need for earlier IVIG/SCIG treatment.
This is an observational study that looks at people who were suspected to have Guillain-Barré syndrome and were cared for at University Hospital of Basel in the past. It does not test a new treatment—researchers review existing care to learn more about this condition.
This trial tests a new medicine called efgartigimod for people with Guillain-Barré syndrome (GBS), a condition where the immune system attacks the nerves. The medicine aims to reduce the immune attack and help you recover faster. It is for people who started having GBS symptoms within the last 2 weeks and have moderate to severe symptoms.
This study tests if ultrasound can find nerve problems in people with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), and if it helps doctors diagnose and predict outcomes early.
This study uses ultrasound to look at nerves in people with CIDP to help guide treatment. It aims to see if ultrasound can help doctors choose the best therapy for each person.
This study looks at how immune-related brain or spinal cord illness shows up using exams, MRI scans, and sometimes a spinal fluid test (lumbar puncture), plus collected blood and other samples. It may help researchers better understand these conditions and improve future diagnosis or treatments.
Hear when a new CIDP - Chronic Inflammatory Demyelinating Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.